Gastrin-Releasing Peptide (1-17) is an N-terminal fragment that retains key motifs for receptor-binding studies. Its composition enables investigation of conformational preferences and signaling initiation. Researchers apply it in mapping structural determinants governing activity. The peptide aids exploration of neuropeptide architecture and downstream biochemical cascades.
CAT No: G03009
1. Myotropic activity of allatostatins in tenebrionid beetles
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.